Parkinson's disease (PD) is one of the most common neurodegenerative disorders that occur in the elderly. Until now, the cause and mechanism of PD are unknown, making further studies necessary. S100B is a member of a group of Ca 2ϩ -binding protein mostly astrocytederived factor that has been shown to be involved in the maintenance and stimulation of neurons and glia cells by regulating a variety of cellular mechanisms such as proliferation, differentiation and energy metabolism. Increased levels of S100B were detected in the serum of the patients of PD.
-binding protein mostly astrocytederived factor that has been shown to be involved in the maintenance and stimulation of neurons and glia cells by regulating a variety of cellular mechanisms such as proliferation, differentiation and energy metabolism. Increased levels of S100B were detected in the serum of the patients of PD. 1, 2) The expression of S100B in the substantia nigra and striatum of mice has a close relationship with a decreased number of dopaminergic neurons after injecting 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into the abdominal cavity of mice. 3) We conclude that S100B has a close relationship with the development of PD, but are still unsure of a concrete mechanism. To reveal the effects of over-expression of S100B on the metabonomics of endogenous components in the brain is very helpful to investigate the mechanism of S100B in the development of PD.
Metabonomics, defined as "the quantitative measurement of the dynamic multiparametric metabolic response of living organism to pathophysiological stimulation or genetic modification," 4) combined with multivariate analysis, has been extensively applied to many fields, such as understanding the biochemical basis of diseases, drug toxicity and diagnosis, and treatment of diseases according to the global metabolic profiles in biological fluids (serum, plasma, urine) and tissues. [5] [6] [7] [8] Metabonomics study was divided into four levels, including target analysis, profiling analysis, fingerprint analysis and metabonomics analysis. In this paper, metabonomics study based on the HPLC/MS-ESI-TOF analysis was applied to understanding the metabolic profiling of S100B transgenic mice and identifying the potential biomarkers relating to S100B protein.
Besides of high-field proton nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC) coupled with MS has been widely applied for metabolic profiles of biological samples and reversed-phase (RP) chromatography is the most commonly used separation technique. Although it is impossible to determine the individual level of every single endogenous metabolite in a biofluid, to obtain a metabolic fingerprint, preferably as many metabolites as possible, should be detected. It was found that the most polar components in biological samples would not have been retained on the RP chromatography column, and could not be detected. Hydrophilic interaction liquid chromatography (HILIC) is a complementary method to RP chromatography. HILIC is similar to normal phase chromatography and the separation is based on the distribution between stationary and mobile phases, although it differs with RP chromatography in that aqueous mobile phases can be used. 9) In this paper, with the aim of increasing the number of metabolites to be detected, RP-LC and HILIC were combined. With this method, it is possible to analyze the less polar compounds by using RP column, and the more polar fraction can be analyzed by using the HILIC column.
In this study, the model of brain-specific human S100B transgenic mice was established. Corresponding mesencephalon samples were collected for the metabonomics analysis by using RP-LC/MS-ESI-TOF and HILIC-LC/MS-ESI-TOF. Principal component analysis (PCA) was performed for investigating the metabolic changes in mesencephalon of transgenic mice, and the potential biomarkers were identified according to accurate mass, meanwhile, the pathobiological mechanism of PD caused by S100B protein was supposed.
MATERIALS AND METHODS

Establishment of S100B Transgenic Mice Model
Human S100B gene sequence with HindIII and XhoI restriction sites was obtained from vector pOTB7-hS100B (Invitrogen, CA, U.S.A., Catalog#3543825) using the following polymerase chain reaction (PCR) primers: Sense 5Ј-TTT-TAAGCTTCACCATGTCTGAGCTGGAGAAGGC-3Ј and the antisense 5Ј-TTTTCTCGAGTTGCATGACCGTCTCTGT-TACAG-3Ј. The platelet-derived growth factor (PDGF) promoter is brain specific and was obtained from the vector PsisCAT6a (gifted by doctor Tucker Collins, Harvard Medical School) using HindIII and BamHI restriction enzymes. The S100B sequence and the promoter were subcloned into the vector pCEP4 (Invitrogen, CA, U.S.A., Catalog#V04450) by digestion with BglII and XhoI, generating a vector including a PDGF promoter driving hS100B. DNA sequence of this vector was confirmed by sequencing analysis. The PDGFhS100B containing vector was linearized with XbaI, and micro-injected into C57BL/6 fertilized mouse eggs. The founder mice were identified by PCR using the following primers: sense 5Ј-ATTCTGGAAGGGAGGGAGA-3Ј and antisense 5Ј-TGGCAGGCAGTAGTAACCAT-3Ј. Of the five founder mice, the one with the highest level of hS100B expression was selected for breeding. The offsprings used in this study were obtained by backcrossing into C57BL/6 mouse strain. The male hS100B-expressing transgenic mice were selected and used for all experiments and the male nontransgenic mice were used as control. All the mice were housed in individually ventilated cages separately with a 12-h light on/off cycle at a temperature of 25Ϯ2°C with the humidity from 45 to 65% and water and food ad libitum.
Detection of Motor Coordination by Rota-Rod Test
The Rota-rod test was carried out to detect motor coordination of mice at ages three and seven months, respectively. There were twelve mice in each group. Mice were trained for 5 min to make them stay on Rota-rod treadmills at a rolling speed of 24r/min. The experiment was performed after a 2 min rest interval following the training. The residence time of the mice on Rota-rod treadmills was recorded and an average of the residence time from five tests was calculated.
Chemicals and Reagents The reference standards of arginine (Arg), aminoethylsulfonic acid (TAU), Trp, GABA, Phe, Glu, hippuric acid, adenine, aminosalicylic acid and His were purchased from Sigma-Aldrich Inc. (Milwaukee, WI, U.S.A.). Acetonitrile of HPLC grade was purchased from Tedia Co. (Fairfield, OH, U.S.A.). Other chemicals were all of analytical grade. Deionized water was prepared using a Millipore Milli Q-Plus system (Millipore, Bedford, MA, U.S.A.).
Samples and Preparation Twelve mice samples of seven months age, including S100B transgenic mice (nϭ6) and control (nϭ6), were determined. After decapitation, mesencephalon was dissected on a cold plate (Ϫ16°C) and weighed accurately. The mesencephalon samples were immediately frozen on dry ice and stored at Ϫ80°C until used. For determination, mesencephalon tissue blocks were thawed on ice. Once thawed, 2 ml ice-cold methanol was added and homogenized with a tissue homogenizer for 2 min in iced bath. Aliquots of 1 ml homogenate was suctioned and centrifuged at 2000ϫg for 20 min at 4°C. The upper organic layer was transferred into another tube and evaporated to dryness under nitrogen stream and the residue dissolved with 100 ml of distilled water and vortexed for 1 min. The mixture was vortexmixed with 100 ml of chloroform-isopropanol (10 : 3, v/v) for 2 min and centrifuged at 3000ϫg for 5 min. An aliquot of 10 ml supernatant water phase was injected into the HPLC-QTOF for analysis.
Liquid Chromatography Liquid chromatography was performed on an Agilent 1100 HPLC system (Agilent Technologies) equipped with a quaternary solvent delivery system, an on-line degasser, an autosampler, a column temperature controller.
The RP chromatographic separation was achieved on an Agilent Zorbax SB-C18 reserved phase column (150ϫ4.6 mm i. Mass Spectrometry The mass spectrometry was performed on an Agilent 6510-QTOF (Agilent Technologies, Palo Alto, CA, U.S.A.). The ESI source was set in positive and negative ionization mode, respectively. For positive ionization mode, the MS conditions were as follows: The flow rate of desolvation gas was 500 l/h at the temperature of 300°C. The nebulization gas was set at 30 psi. The source temperature set to 120°C. The capillary and cone voltages were set at 3000 and 35 V, respectively. For negative ionization mode, due to lower sensitivity compared with in positive ionization mode, the nebulization gas was set at 40 psi. Other parameters were the same. For MS experiments, with the TOF data being collected between m/z 50-1000, with the collision energy set at 10 eV. To ensure accuracy and reproducibility, leucine-enkephalin was used as the lock mass (m/z 556.2771) at a concentration of 50 fmol/ml and flow rate of 6 ml/min. Data were collected in centroid mode, the LockSpray frequency was set at 5 s, and data were averaged over 10 spectra.
Data Analysis In order to be subjected to peak picking, the raw data were processed by the Molecule Feature Extraction of Mass Hunter. The noise calculation was supported by the cutoff of 0.1% base peak. Picked peaks were aligned according to the retention time (t R ) and m/z of each ion, and a matrix including the retention time, m/z and respective ion intensities was generated by the software using a mass clustering window of 0.005 Da and the retention time clustering window of 0.1 min. These data were processed according to the "80% rule," 10, 11) briefly, only the variables with values above zero presenting in at least 80% of each group were kept for the following analysis. The normalized data were processed by PCA utilizing MPP (Agilent Technologies).
Method Validation Because metabonomics asks for method robustness, this method was validated for its precision and stability. Some extracted ion chromatographic peaks (shown in Fig. 1 ) were selected for method validation, including Arg detected in RP ESI ϩ mode, TAU detected in RP ESI Ϫ mode, Trp and GABA detected in HILIC ESI ϩ mode, and Phe detected in HILIC ESI Ϫ mode. Precision A mouse mesencephalon sample of control group was analyzed for conducting precision test. It was measured by intra-day and inter-day variability. For intra-day variability, a sample was examined for six replicates within 1 d. For inter-day variability, a sample was examined in duplicates over three consecutive days. The relative standard deviations of retention time, m/z and ion fragment peak areas of the five investigated compounds, including Arg, TAU, Trp, GABA and Phe, were calculated.
Stability The post-preparation stability of sample was tested by analyzing a mouse mesencephalon sample of control left at autosampler (maintained at 4°C) for 4, 8, 12 and 24 h. The relative standard deviations and the mean relative errors of peak areas of the five investigated compounds, including Arg, TAU, Trp, GABA and Phe, were calculated.
RESULTS AND DISCUSSION
Rota-Rod Test PD is one of the most common neurodegenerative disorders that occur in the elderly. Behavioral changes such as hypokinesia, bradykinesia were observed in mouse model of PD. The Rota-rod test is a reliable index for evaluating the motor coordination of mouse. By performing this test, we found that the residence time of mouse on Rotarod treadmills was shorter in S100B transgenic group. The decreased residence time on Rota-rod treadmills was positively correlated with aging. The motor coordination in S100B transgenic mice was significantly decreased by 39.1% and 50.2% at the ages of 3 and 7 months old, respectively, when compared with control group (Fig. 1) , indicating a progressive decline of motor coordination in S100B transgenic mice. Previous studies [1] [2] [3] and the result of Rota-rod test indicated the association of S100B with PD. Therefore, the establishment of brain specific S100B transgenic mouse can be used as an animal model for the research of PD.
Combined Using of RP Column and HILIC Column In this paper, two complementary chromatographic methods were used with the aim of increasing the number of metabolites to be detected. With this method, it is possible to analyze the less polar compounds by using RP, and the more polar fraction by using HILIC. For RP, three chromatographic columns were compared: Agilent Zorbax SB-C18 (150ϫ4.6 mm i.d., 5 mm), Kromasil C18 (150ϫ4.6 mm i.d., 5 mm), and Diamonsil TM C18 (150ϫ4.6 mm i.d., 5 mm). It was found that, for all the investigated compounds, Agilent Zorbax SB-C18 produced a better separation. For HILIC, an Alltima HP HILIC (2.1ϫ150 mm, 3 mm) column (Waters, Ireland) was used. The gradient steepness was adjusted as described at the "Liquid Chromatography." When the test solutions were analyzed by the two types of column and proposed procedure, respectively, the representative chromatograms (Fig. 2) were obtained.
Method Validation. Precision Table 1 summarized the precision based on the analysis of Arg, TAU, Trp, GABA and Phe in a mouse mesencephalon sample of control. The relative standard deviations of retention time, m/z and ion fragment peak areas were calculated. For intra-day precision, the relative standard deviations of retention time and ion peak areas were from 0.07 to 0.29% and from 0.21 to 1.51%, respectively; those of m/z were 0-0.01%. For inter-day precision in 3 d, the relative standard deviations of retention time and ion peak areas were from 0.09 to 0.39% and from 0.36 to 1.27%, respectively; those of m/z were 0-0.01%. The results indicated that the method showed good precision.
Stability The sample solution of control mouse was found to be stable at 4°C for 24 h. The relative standard deviations and the mean relative errors of the five investigated compounds' peak areas being subjected to certain conditions were shown in Table 2 . The results indicated the good stability of the sample solution stored at 4°C for 24 h.
Sample Analysis To gain an overview of the metabolic profiling, PCA, being an unsupervised multivariate data analysis method, which gives the comprehensive view of the clustering trend for the multidimensional data, was used in the subsequent MS data analysis. The profile showed that the established model was capable of differentiating the S100B transgenic mice from control group. Figure 3 showed the 3D PCA score plot of the S100B transgenic mice and the control based on metabolic profiles. In the plots, the transgenic mice and the control group were separated clearly in the four different experiment methods (RP ESI ϩ mode, RP ESI Ϫ mode, HILIC ESI ϩ mode and HILIC ESI Ϫ mode). The results from the unsupervised analysis of PCA showed the significant metabolic changes occurring in the S100B transgenic mice.
Identification of Potential Biomarkers The significant metabolites related to the group separation were selected as potential biomarkers from the S-plots of PCA by MPP software. These metabolites had high correlation with S100B protein. They were important for classification of S100B transgenic mice and the control. The potential biomarkers were identified by comparing with the accurate mass in some database, including HMDB, KEGG, METLIN, LIPID MAPS Comparisons between groups were made using Student's t-test after homogeneity of variance test. * pϽ0.05, versus the control group. and PUBCHEM, in combination with their corresponding fragments of product ion scan in the positive and negative ion mode. Table 3 and Table 4 listed twelve potential biomarkers identified for classifying S100B transgenic mice with the control, including Arg, hippuric acid, TAU, adenine, Glu, 5-methoxytryptamine, Trp, GABA, hydroxyproline, aminosalicylic acid, Phe and His.
Except for 5-methoxytryptamine and hydroxyproline unavailability, the relative intensities of other ten putative potential biomarkers in the control group and S100B transgenic mice were compared (shown in Fig. 4) . The results showed that concentrations of GABA, Glu, His, TAU, adenine, aminosalicylic acid and Arg in the mesencephalons of S100B transgenic mice were up-regulated, but Phe, Trp and hippuric acid were down-regulated.
Study of Metabolic Changes of Glu, GABA, Phe, Trp, and His in S100B Transgenic Mice It was reported that over-expression of S100B related to PD and PD related to abnormal metabolism of neurotransmitters in central nervous system, so investigating the effects of S100B on neurotransmitters is an incision point of studying the possible mechanism of S100B in PD. In this paper, we found that twelve putative potential biomarkers relating to S100B protein, and the relative intensities of ten varied with it, but among them, the relations between five amino acids (Glu, GABA, Phe, Trp and His) and neurotransmitters or metabolism of neurotransmitters in central nervous system were clear, but the relations between others (Arg, hippuric acid, TAU, adenine, 5-methoxytryptamine, hydroxyproline and aminosalicylic acid) and neurotransmitters or PD have not been discovered by now. So, the five potential biomarkers (Glu, GABA, Phe, Trp and His) in the mesencephalon were emphasized to discuss.
Neurotransmitters were divided into two main categories, amino acid and monoamine. Glu and GABA belong to amino acid neurotransmitters. The metabolites of Phe, Trp and His belong to monoamine neurotransmitters. Glu is excitatory neurotransmitter. GABA is inhibitory neurotransmitter. They were reported to participate in the pathogenesis of PD. 12, 13) In addition, the changes of monoamines levels were also detected in patients with PD, 14) but little evidence exists on how endogenous S100B protein influences in the metabolic path- way of these monoamines. In our study, Phe was identified as a potential biomarker for differencing expression content of S100B. In central nervous system, many kinds of important monoamine neurotransmitters relate to metabolism of Phe, such as dopamine, norepinephrine, epinephrine and so on (Fig. 5) . The rationality of Phe as the potentional biomarker was also confirmed in reverse side. The metabolic pathway (shown in Fig. 6 ) of Trp in central nervous system is consisted of Trp→5-hydroxytryptophan→5-hydroxytryptamine, and 5-hydroxytryptamine is an important mediator. It also verified the rationality of Trp as the potentional biomarker. Histamine, generated by decarboxylation reaction of His, is a new found neurotransmitter, and it was reported up-regulated in cerebrum of PD. As an acidic calcium binding protein, over-expression of S100B protein has toxic effects on the central nervous system (CNS), where it can produce damage of central neurons via inducing intracellular [Ca 2ϩ ] abnormal increase and calcium overload, 16) increasing the expression of inducible nitric oxide syntheses and subsequent release of nitric oxide, 17) and stimulating activation of microglia and astrocyte. 18) So, overexpression of S100B promotes the dysfunction and neurotransmitters metabolic disorder in nervous system. The changes of abnormal metabolism of Glu, GABA, Phe, Trp and His in mesencephalon could participate in the development of PD.
CONCLUSION
In this study, a sensitive and precise metabonomics method, based on /MS-ESI-TOF, was applied to investigate the metabolic changes in mesencephalon of S100B transgenic mice. Five amino acids relating to neurotransmitters were identified as potential biomarkers by using metabonomics method combined with multivariate data analysis. The results showed abnormal metabolism of Glu, GABA, Phe, Trp and His in S100B transgenic mice. If it can be verified by further pharmacological experiments, combined with genomics, metabonomics will give a better and further understanding of pathologic mechanism of S100B in PD. 
